Literature DB >> 28686158

Diagnosis and management of patients with von Willebrand's disease in Italy: an Expert Meeting Report.

Flora Peyvandi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28686158      PMCID： PMC6034766          DOI： 10.2450/2017.0131-17

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  19 in total

Review 1.  Treatment of von Willebrand's Disease.

Authors:  Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

Review 2.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

Review 3.  Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.

Authors:  T Abshire; J Cox-Gill; C L Kempton; F W G Leebeek; M Carcao; P Kouides; S Donfield; E Berntorp
Journal:  J Thromb Haemost       Date:  2015-07-14       Impact factor: 5.824

4.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 5.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Authors:  J E Sadler; U Budde; J C J Eikenboom; E J Favaloro; F G H Hill; L Holmberg; J Ingerslev; C A Lee; D Lillicrap; P M Mannucci; C Mazurier; D Meyer; W L Nichols; M Nishino; I R Peake; F Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; A B Federici
Journal:  J Thromb Haemost       Date:  2006-08-02       Impact factor: 5.824

Review 6.  Gynecological and obstetrical manifestations of inherited bleeding disorders in women.

Authors:  F Peyvandi; I Garagiola; M Menegatti
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

7.  Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease.

Authors:  M Lak; F Peyvandi; P M Mannucci
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

8.  Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.

Authors:  Augusto B Federici; Claudine Mazurier; Erik Berntorp; Christine A Lee; Inge Scharrer; Jenny Goudemand; Stephan Lethagen; Ioana Nitu; Gerard Ludwig; Lysiane Hilbert; Pier M Mannucci
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

9.  Biosynthesis of von Willebrand protein by human megakaryocytes.

Authors:  L A Sporn; S I Chavin; V J Marder; D D Wagner
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.